Clinical Trials Logo

Filter by:
NCT ID: NCT01220947 Completed - Clinical trials for Hepatitis C, Chronic

A Study of Danoprevir Boosted With Low Dose Ritonavir in Combination With Pegasys and Copegus in Treatment-Naive Patients With Chronic Hepatitis C Virus Infection

Start date: November 2010
Phase: Phase 2
Study type: Interventional

This randomized, open-label, active-controlled, parallel-group study will evaluate the sustained virological response of danoprevir boosted with low dose ritonavir in combination with Pegasys (peginterferon alfa-2a) and Copegus versus Pegasys and Copegus alone in treatment-naive patients with chronic Hepatitis C.

NCT ID: NCT01217814 Terminated - Clinical trials for Rheumatoid Arthritis

Effect of SAR153191 (REGN88) With Methotrexate in Patients With Active Rheumatoid Arthritis Who Failed TNF-α Blockers

Start date: November 2010
Phase: Phase 2
Study type: Interventional

Primary Objective: - Demonstrate that sarilumab (SAR153191/REGN88) on top of methotrexate [MTX] is superior in efficacy to placebo for the relief of signs and symptoms of Rheumatoid Arthritis [RA], in patients with active RA who have failed up to 2 Tumor Necrosis Factor α [TNF-α] antagonists. Secondary Objectives: - Assess the safety of sarilumab; - Document the pharmacokinetic profile of sarilumab.

NCT ID: NCT01217762 Active, not recruiting - Clinical trials for Age-Related Macular Degeneration

Safety & Tolerability of the IRay System in Subjects With Exudative Choroidal Neovascularization (CNV) Secondary to Age-Related Macular Degeneration (AMD)

Start date: July 2008
Phase: Phase 1
Study type: Interventional

The purpose of this study is to evaluate the safety and clinical feasibility of the IRay System for the treatment of wet age-related macular degeneration (AMD).

NCT ID: NCT01217697 Approved for marketing - Clinical trials for Urogenital Neoplasms

Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer

Start date: n/a
Phase: N/A
Study type: Expanded Access

The purpose of this study is to collect additional safety information on abiraterone acetate administered with prednisone to patients with metastatic castration-resistant prostate cancer (CRPC).

NCT ID: NCT01215955 Completed - Clinical trials for Diabetes Mellitus, Type 2

Study of Insulin Lispro in Participants With Inadequately Controlled Type 2 Diabetes

AUTONOMY
Start date: December 2010
Phase: Phase 4
Study type: Interventional

Evidence regarding optimal methods of insulin dose adjustment is lacking in the literature. The purpose of this study is to evaluate the efficacy and safety of two approaches to escalate prandial insulin therapy in participants with type 2 diabetes mellitus not achieving adequate glycemic control on basal insulin.

NCT ID: NCT01215942 Terminated - Clinical trials for Rheumatoid Arthritis

An Open Label Study for Participants With Rheumatoid Arthritis

Start date: June 2011
Phase: Phase 3
Study type: Interventional

The primary purpose of this study is to help answer if LY2127399 is safe and effective during long-term treatment in participants with Rheumatoid Arthritis. This study is comprised of 2 periods: Period 1: Unblinded treatment for up to 240 weeks for participants who enroll from Study H9B-MC-BCDO (BCDO) (NCT01202760) or Study H9B-MC-BCDV (BCDV) (NCT01202773) or up to 168 weeks for participants who enroll from Study H9B-MC-BCDM (BCDM) (NCT01198002). Period 2: 48-week post-treatment follow-up

NCT ID: NCT01209780 Completed - Seasonal Influenza Clinical Trials

Safety and Immunogenicity of Trivalent Subunit Inactivated Flu Vaccine Administered to Healthy Children and Adolescents 3 to 17 Years of Age

Start date: September 2010
Phase: Phase 3
Study type: Interventional

This study will evaluate the safety and immunogenicity in healthy children and adolescents after one or two IM dose(s) of trivalent subunit inactivated flu vaccine.

NCT ID: NCT01207830 Completed - Obesity Clinical Trials

Feasibility Trial of ValenTx Endo Bypass System of the ValenTx Endo Bypass System in Obese Subjects

Start date: March 2010
Phase: N/A
Study type: Interventional

The purpose of this study is to provide initial clinical data to support the feasibility of use of the ValenTx Endo Bypass system in enhancing weight loss and co-morbidity resolution in morbidly obese subjects

NCT ID: NCT01207804 Completed - Obesity Clinical Trials

Feasibility Trial of ValenTx Endo Bypass System

Start date: August 2008
Phase: N/A
Study type: Interventional

The purpose of the study is to provide initial clinical data to support the feasibility of use of the ValenTx Endo Bypass system in enhancing weight loss and co-morbidity resolution in morbidly obese patients.

NCT ID: NCT01205477 Completed - Bursitis Clinical Trials

Safety and Efficacy of Methylprednisolone Infiltration in Anserine Bursitis Treatment

Start date: September 2009
Phase: Phase 2
Study type: Interventional

To investigate the safety and efficacy of methylprednisolone infiltration in anserine bursitis treatment